Product Information
ETODOLAC ER 500 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.7176 per EA under NDC 00093717201. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jul 31, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093717201
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ETODOLACApproval Type
Generic (ANDA)
FDA Application
ANDA075665FDA Approved
7/31/2000
TE Code
AB
On Market Since
8/11/2000
Pharmacological Classes
Price Statistics
The NADAC for ETODOLAC ER 500 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 62.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7176 per EA |
|---|---|
| All-time high | $2.4199 (Apr 16, 2014) |
| All-time low | $0.7176 (Sep 23, 2026) |
| 52-week high | $0.9521 |
| 52-week low | $0.7176 |
| Median price | $1.4969 |
| Average price | $1.5905 |
| Largest weekly change | -30.7% (Jul 19, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 60% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Etodolac market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ETODOLAC ER 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ETODOLAC ER 500 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.7176 per EA (NDC 00093717201), effective Sep 30, 2026.
How has the price of ETODOLAC ER 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for ETODOLAC ER 500 MG TABLET has declined 62.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ETODOLAC ER 500 MG TABLET?
Since Nov 28, 2013, the NADAC for ETODOLAC ER 500 MG TABLET has ranged from a low of $0.7176 (Sep 23, 2026) to a high of $2.4199 (Apr 16, 2014), with a median of $1.4969 per EA.
Are there cheaper alternatives to ETODOLAC ER 500 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ETODOLAC 500 MG TABLET, is $0.2852 per EA — about 60% below ETODOLAC ER 500 MG TABLET.
Who manufactures ETODOLAC ER 500 MG TABLET?
ETODOLAC ER 500 MG TABLET (NDC 00093717201) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.